The leading source for credible citizen reporting

Report Your News
Take the tour...

Pfizer halts enrollment in lung cancer trial

Source: Inquirer.net
Manila : Philippines | about 1 month ago  
Views: 7
  • A researcher work on trying to find a breakthrough cancer treatment
    A researcher work on trying to find a breakthrough cancer treatment
    Source: AFP
A researcher work on trying to find a breakthrough cancer treatment
Pfizer Inc has halted patient enrollment in a late-stage lung cancer trial of its experimental drug, figitumumab, for safety reasons, the drugmaker said on Friday. The halt was recommended by independent safety monitors overseeing the study. In their review, the monitors found more serious adverse...
  • Print
  • Share:
  • Share
  • Digg
  • Reddit
  • Facebook
  • Stumbleupon

Related Allvoices Contributions

News Stories
 
  • News Source: The Day | about 1 month ago
    Pfizer Inc. has stopped enrolling patients in one late-stage clinical trial of a drug designed to treat lung cancer after testing resulted in an increase in adverse reactions, including fatalities. The drug, known as figitumumab, was first discovered...
  • News Source: Inquirer.net | about 1 month ago
    Pfizer Inc has halted patient enrollment in a late-stage lung cancer trial of its experimental drug, figitumumab, for safety reasons, the drugmaker said on Friday. The halt was recommended by independent safety monitors overseeing the study. In their...
Blogs
 >
Images
 >
 
Videos
 >
 
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Cell phones Cell phones use report code: @4355424

Most Popular Reports

Related Allvoices Reports

Contributions

Help and Accounts


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2009. All rights reserved.